Standout Papers

Considerations for Formulating the Second-Generation Pneumococcal Capsular Polysaccharide Vac... 1983 2026 1997 2011 466
  1. Considerations for Formulating the Second-Generation Pneumococcal Capsular Polysaccharide Vaccine with Emphasis on the Cross-Reactive Types Within Groups (1983)
    John B. Robbins, Robert Austrian et al. The Journal of Infectious Diseases

Immediate Impact

1 by Nobel laureates 3 from Science/Nature 56 standout
Sub-graph 1 of 22

Citing Papers

Direct radical functionalization of native sugars
2024 StandoutNature
Synthetic Glycans to Improve Current Glycoconjugate Vaccines and Fight Antimicrobial Resistance
2022 Standout
6 intermediate papers

Works of J Henrichsen being referenced

Influence of prevaccination immunity on the human B-lymphocyte response to a Haemophilus influenzae type b conjugate vaccine
1991
Considerations for Formulating the Second-Generation Pneumococcal Capsular Polysaccharide Vaccine with Emphasis on the Cross-Reactive Types Within Groups
1983 Standout

Author Peers

Author Last Decade Papers Cites
J Henrichsen 621 142 113 328 211 17 943
David E. Briles 797 260 122 425 204 18 1.1k
Jane M. Gould 531 123 121 314 127 22 872
Philip P. Vella 813 182 92 465 41 26 1.0k
Lorry G. Rubin 633 69 88 587 90 18 1.1k
C Forman 568 440 183 320 159 12 1.1k
Emilie Camberlein 576 181 141 316 199 24 906
J M Griffiss 370 246 244 553 55 20 910
Lionel Tan 410 94 102 302 170 30 806
Eija Kela 507 56 92 436 100 18 943
C C Patrick 416 102 339 190 61 34 1.1k

All Works

Loading papers...

Rankless by CCL
2026